K. A. Ryzhykova

Effect of CYP3A5*3 polymorphism on anti-inflamatory therapy in children with bronchial asthma

E. Grishina, I. Zakharova, A. Zastrozhina, 2019, Medical Council.

Pharmacogenetic evaluation of adverse events’ risk in patients with alcohol withdrawal syndrome taking bromdihydrochlorphenylbenzodiazepine: The role of CYP2C19 gene polymorphisms

M. Zastrozhin, E. Grishina, E. Bryun, 2017 .

Pharmacogenetics biomarkers of antipsychotics’ safety in adolescents with acute psychotic episode

D. Sychev, D. Ivashchenko, N. Buromskaya, 2019, V.M. BEKHTEREV REVIEW OF PSYCHIATRY AND MEDICAL PSYCHOLOGY.